Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect
Italian Journal of Medicine · 06.11.2026 · 20 (4)
DOI: 10.4081/itjm.2026.2418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Italian Journal of Medicine, online erschienen am 06.11.2026. Verfasst von Sandra Provenzano und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Dear Editor,While common adverse events associated with sodium-glucose cotransporter-2 inhibitors, such as genitourinary infections and volume depletion, are well-characterized, rare immune-mediated cutaneous manifestations are increasingly recognized in post-marketing surveillance...
Zitieren
APA
Provenzano, S., Visioli, S., Ribattezzato, V., & Modugno, M. (2026). Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect. Italian Journal of Medicine, 20(4). https://doi.org/10.4081/itjm.2026.2418
Vancouver
Provenzano S, Visioli S, Ribattezzato V, Modugno M. Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect. Italian Journal of Medicine. 2026;20(4). doi:10.4081/itjm.2026.2418
BibTeX
@article{Provenzano2026,
author = {Provenzano, Sandra and Visioli, Sandra and Ribattezzato, Valeria and Modugno, Maria},
title = {Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect},
journal = {Italian Journal of Medicine},
year = {2026},
volume = {20},
number = {4},
doi = {10.4081/itjm.2026.2418}
}
EUVIMED